Premier Biomedical, Inc.
BIEI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $4 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $0 | $4 | $0 | $0 |
| Property Plant & Equip (Net) | $3 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $3 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3 | $7 | $3 | $3 |
| Liabilities | – | – | – | – |
| Payables | $362 | $0 | $0 | $216 |
| Short-Term Debt | $608 | $568 | $437 | $436 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,615 | $1,921 | $1,846 | $1,600 |
| Total Curr. Liab. | $2,584 | $2,489 | $2,283 | $2,252 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,584 | $2,489 | $2,283 | $2,252 |
| Equity | – | – | – | – |
| Pref Stock | $2 | $2 | $2 | $2 |
| Common Stock | $10 | $11 | $10 | $10 |
| Retained Earnings | -$17,954 | -$17,855 | -$17,653 | -$17,604 |
| AOCI | $0 | -$11 | -$9 | -$10 |
| Other Equity | $15,361 | $15,371 | $15,370 | $15,353 |
| Total Equity | -$2,581 | -$2,482 | -$2,280 | -$2,249 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3 | $7 | $3 | $3 |
| Net Debt | $607 | $564 | $437 | $436 |